In addition, mannan-binding lectin serine protease (MASP2), a serum protease that plays an important role in the activation of the complement system via mannose-binding lectin, was downregulated in the sEV fractions of the bladder cancer patients. Here, MASP2 is linked to urinary bladder cancer.